# OnCo record ian-krop (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ian-krop/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ian-krop" ;
  schema:name "Ian E. Krop"@en ;
  schema:description "Breast oncologist who took T-DM1 and then trastuzumab deruxtecan from first-in-human studies to approval."@en ;
  schema:url <https://onco.cc/people/ian-krop/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Krop%20IE%5BAuthor%5D%20trastuzumab%20emtansine%20OR%20deruxtecan> ;
  onco:tag "breast", "adc", "her2" ;
  schema:jobTitle "Associate Cancer Center Director for Clinical Research, Yale Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0002-6380-5944> ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-emtansine/>, <https://onco.cc/drugs/trastuzumab-deruxtecan/> ;
  onco:institutions <https://onco.cc/institutions/yale-cancer-center/> ;
  onco:trials <https://onco.cc/trials/destiny-breast03/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-destiny-breast03-nejm-2022/> ;
  schema:affiliation <https://onco.cc/institutions/yale-cancer-center/> .